NZX50 slides to nine-month low

NZX50 slides to nine-month low
A new drug has weighed on Fisher and Paykel's shares. (Image: Getty)
Graham Skellern
A weight-reducing drug is causing trouble for Fisher and Paykel Healthcare as the New Zealand sharemarket chalked up its sixth successive fall.The S&P/NZX 50 Index was on a downward slide all day and closed at 11,344.11, down 82.73 points or 0.72% – its lowest level for nine months.The index has now fallen 1.8% for the year and was at 11308.31 points on November 28.There were 42 gainers and 84 decliners on the main board, with 28.19 million shares worth $102.5m changing hands.Under pressureMarket heavyweight Fisher and Paykel Healthca...

More Markets

NZX rallies past 13,000 points after RBNZ rate cut
Markets Market Close

NZX rallies past 13,000 points after RBNZ rate cut

The NZ sharemarket was up after results from Fletcher Building and Spark.

Tom Raynel 20 Aug 2025
Major SkyCity investor ready to vote against directors
Markets

Major SkyCity investor ready to vote against directors

Allan Gray says an equity raise now would show the board to be poor stewards of capital.

Dileepa Fonseka 20 Aug 2025
Spark resets future dividend ratios, unveils new strategy
Markets

Spark resets future dividend ratios, unveils new strategy

Spark promises a return to basics and 'annuity-like' returns.

Pattrick Smellie 20 Aug 2025
‘One of the most challenging periods in Spark’s history’
Markets

‘One of the most challenging periods in Spark’s history’

Spark has reported another big fall in profit, with reported net profit down 17.7% to $260 million, or a 33.6% fall to $227m, adjusting for asset sales and other one-offs.“The past year has been one of the most challenging periods in Spark’s history, as we navigated economic head...

Staff reporters 20 Aug 2025